New: Combined rapid test for Covid-19 and influenza

Share
Corona numbers are rising, and the next challenge is already in sight: Flu season is beginning. The symptoms can be very similar, but a test can differentiate between influenza and Covid-19. A new combined rapid test can detect coronavirus and influenza viruses simultaneously: The NADAL® COVID-19 Ag+Influenza A/B Test from German medical technology company nal von minden delivers a reliable result in just 15 minutes.

Symptoms like fever, cough, sore throat and fatigue can occur with both influenza and Covid-19 infections. Suspected coronavirus cases could therefore actually be influenza cases – or vice versa.

"Differentiating between coronavirus and influenza is enormously important in order to avoid further spread of the coronavirus and to protect ourselves and others faster and better", says Thomas Zander, managing director of nal von minden GmbH, based in Moers, Germany. "The new combined rapid test for Covid-19 and influenza can help contain the spread of the virus."

The NADAL® COVID-19 antigen/influenza combined test can be carried out on site. A laboratory is not necessary. For the test, a swab from the oral cavity or nasopharynx is collected by medical personnel. The result is available within 15 minutes. Zander: "It is much more pleasant for affected individuals to have just one sample collected, rather than two, to check for two possible infections." The new combined test also takes the pressure off laboratories, which cannot process unlimited numbers of time-consuming tests.

Possible areas of application for the new combined test are primarily nursing and care homes, as older people are particularly at risk. The combined test is also useful in hospitals, for example in case of rapid emergency admission of patients. It could also be used within companies to test employees with unclear cold symptoms. "However, within a company, the test must be carried out by a doctor", adds Zander.

nal von minden GmbH has already produced millions of combined antigen tests, which are available immediately. The test is already approved throughout Europe.

Picture is available at AP Images (http://www.apimages.com

Contacts

Hellwig PR
Gabriele Hellwig
+49 40 38 66 24 80
info@hellwig-pr.de

Images

About nal von minden GmbH

nal von minden GmbH

Moers

Subscribe to releases from nal von minden GmbH

Subscribe to all the latest releases from nal von minden GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from nal von minden GmbH

Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 14:48:24 CET | Pressemeddelelse

In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.

New study: Only reliable rapid corona tests make sense3.12.2020 11:58:51 CET | Press release

More and more manufacturers are bringing corona rapid tests onto the market. But only if they provide reliable results does their use in the fight against the pandemic makes sense. The Charité hospital in Berlin, one of the largest university hospitals in Europe, has now reviewed the performance of corona antigen rapid tests. The corona rapid test from nal von minden GmbH proved to be particularly reliable. The NADAL® COVID-19 Ag rapid test has already been used millions of times throughout Europe during the corona pandemic and provides a result within only 15 minutes.

nal von minden plans to produce 80 million rapid corona tests per month20.11.2020 11:54:07 CET | Press release

Rapid corona testing is playing an increasingly important role in containing the pandemic everywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!

HiddenA line styled icon from Orion Icon Library.Eye